Cost implications of sexual dysfunction: the female picture

Goldmeier, David; Malik, Faisal; Phillips, Richard; Green, John

doi:10.1038/sj.ijir.3901179

Cited by 12 publications

(11 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For example, one publication (excluded from the current review as is was not published in English) estimated that in Germany the direct and indirect costs associated with urinary incontinence following prostatectomy are approximately EUR 71.8 million [73]. Similarly, figures from the UK estimate that on a per patient level, the annual cost of erectile dysfunction is GBP 335 [74].…”

Section: Discussionmentioning

confidence: 99%

Literature review of the burden of prostate cancer in Germany, France, the United Kingdom and Canada

Smith-Palmer¹,

Takizawa²,

Valentine³

2019

BMC Urol

View full text Add to dashboard Cite

BackgroundProstate cancer is the most frequently reported cancer in males in Europe, and is associated with substantial morbidity and mortality. The aim of the current review was to characterize the clinical, economic and humanistic burden of disease associated with prostate cancer in France, Germany, the UK and Canada.MethodsLiterature searches were conducted using the PubMed, EMBASE and Cochrane Library databases to identify studies reporting incidence and/or mortality rates, costs and health state utilities associated with prostate cancer in the settings of interest. For inclusion, studies were required to be published in English in full-text form from 2006 onwards.ResultsIncidence studies showed that in all settings the incidence of prostate cancer has increased substantially over the past two decades, driven in part by increased uptake of prostate specific antigen (PSA) screening leading to earlier identification of tumors, but which has also led to over-treatment, compounding the economic burden of disease. Mortality rates have declined over the same time frame, driven by earlier detection and improvements in treatment. Both prostate cancer itself, as well as treatment and treatment-related complications, are associated with reduced quality of life.ConclusionsProstate cancer is associated with a significant clinical and economic burden, whilst earlier detection and aggressive treatment is associated with improved survival, over-treatment of men with indolent tumors compounds the already significant burden of disease and treatment can lead to long-term side effects including impotence and impaired urinary and/or bowel function. There is currently an unmet clinical need for diagnostic and/or prognostic tools that facilitate personalized prostate cancer treatment, and potentially reduce the clinical, economic and humanistic burden of invasive cancer treatment.Electronic supplementary materialThe online version of this article (10.1186/s12894-019-0448-6) contains supplementary material, which is available to authorized users.

show abstract

Section: Discussionmentioning

confidence: 99%

Literature review of the burden of prostate cancer in Germany, France, the United Kingdom and Canada

Smith-Palmer¹,

Takizawa²,

Valentine³

2019

BMC Urol

View full text Add to dashboard Cite

show abstract

“…Hence, the inadequacies in the basic medical health services for sexual problems are not compensated by an adequate specialized service. Patients have been forced to tolerate a long waiting list for treatment (Goldmeier et al, 2004), or pay high costs for private treatment, or look for alternative or folk methods of management with little scientific basis (Ko, 2003).…”

Section: Treatment Problemsmentioning

confidence: 99%

“…A study by Goldmeier, Malik, Phillips, and Green (2004) investigated the cost of female sexual dysfunction for the NHS each year. Results showed that treatment was beneficial with 80% of patients reporting an improvement in their symptoms.…”

Section: Treatment Problemsmentioning

confidence: 99%

Sexual Disorders, Paraphilias, and Gender Dysphoria

Wylie

Chambers

et al. 2008

International Journal of Sexual Health

View full text Add to dashboard Cite

This article presents an overview of the problems associated with the prevention and management of sexual dysfunction in women and men and the paraphilias, health conditions that have a high impact on world health and development, but have been given unduly little attention. Possible improvements and solutions will be suggested and recommendations made for concerted international actions to go along with the UN Millennium Goals.

show abstract

“…Goldmeier and colleagues calculated that, in 2004, the average costs of the treatment of sexual dysfunctions in the UK for women were €417 when delivered by a psychologist and €896 when delivered by a sex therapist [26]. Potentially, a certain proportion of patients with sexual problems do not require this type of intensive and costly treatment, but can adequately and satisfactorily be treated with less intensive and lower-cost alternatives.…”

Section: Introductionmentioning

confidence: 99%

Research into the efficacy and cost-effectiveness of brief, free of charge and anonymous sex counselling to improve (mental) health in youth: Design of a randomised controlled trial

et al. 2009

View full text Add to dashboard Cite

BackgroundThe capacity to form romantic relationships and sexual health of adolescents in the Netherlands are compromised by several factors, including young age of first intercourse and adolescent depression. Several thresholds like own expenses, trust and embarrassment prevent adolescents to seek help for their sexual problems. To overcome these thresholds, brief sex counselling has been developed. It has been used since 2006 within the Rotterdam-Rijnmond Public Health Service, but there is lack of information about the (cost-) effectiveness. In the current study we will evaluate the (cost-) effectiveness of brief sex counselling for sexual problems in adolescents and young adults between 18 and 25 years of age.MethodsIn a randomised controlled trial we will compare (1) brief sex counselling with (2) intensive sexological treatment, and (3) delayed treatment (waiting list). Embedded in this RCT will be a trial-based economic evaluation, looking at the cost-effectiveness and cost-utility of brief sex counselling versus the two other interventions. Four hundred fifty adolescents (aged 18-25) with sexual problems will be recruited among the persons who visit the Public Health Service (PHS) and through various websites. After a screening procedure, eligible participants will be randomly allocated to one of the three intervention groups. Primary outcome measure of the clinical evaluation is the severity of sexual problems. Other outcomes include psychological distress, especially depression. The economic evaluation will be performed from a societal perspective. Costs will be assessed continuously by a retrospective questionnaire covering the last 3 month. All outcome assessments (including those for the economic evaluation) will take place via the internet at baseline, and at 3, 6, 9, and 12 months after baseline.DiscussionThe proposed research project will be the first study to provide preliminary data about the effect and cost-effectiveness of brief sex counselling in youth in comparison with intensive sexological treatment and delayed treatment. It is anticipated that positive results in (cost-) effectiveness of the proposed intervention will contribute to the improvement of sexual health care for adolescents and young adults.Trial registrationThe study has been registered at the Netherlands Trial Register, part of the Dutch Cochrane Centre (NTR1952)

show abstract

Cost implications of sexual dysfunction: the female picture

Cited by 12 publications

References 19 publications

Literature review of the burden of prostate cancer in Germany, France, the United Kingdom and Canada

Literature review of the burden of prostate cancer in Germany, France, the United Kingdom and Canada

Sexual Disorders, Paraphilias, and Gender Dysphoria

Research into the efficacy and cost-effectiveness of brief, free of charge and anonymous sex counselling to improve (mental) health in youth: Design of a randomised controlled trial

Contact Info

Product

Resources

About